The monoclonal antibody Itolizumab received authorization to start a phase III clinical trial in Covid-19 patients in the US, Mexico and Brazil, reported on Wednesday Cuba's Center for Molecular Immunology (CIM).
The number of people diagnosed with Covid-19 in Cuba today rises to more than seven thousand, after 65 new cases from 10 provinces of this Caribbean nation were reported in the last 24 hours.
The Cuban scientific community is currently working on a third Covid-19 vaccine candidate, the first needle-free injection that would be applied through the nasal tract.
The vaccination campaign against Seasonal Influenza in the Southern Hemisphere began in October in the province of Holguín, aimed at the most vulnerable groups or at risk of suffering from this serious disease.
The Finlay Vaccine Institute of Cuba presented a second vaccine candidate against Covid-19 to the Center for State Control of Medicines, Equipment and Medical Devices (Cecmed), it transcends today.